Cargando…
Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.
Autores principales: | Lara Moscoloni, Luis Felipe, Santarelli, Maximiliano, Spagnuolo, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995483/ https://www.ncbi.nlm.nih.gov/pubmed/33796443 http://dx.doi.org/10.1016/j.eucr.2021.101629 |
Ejemplares similares
-
Tuberculosis epididymo-orchitis following intravesical bacillus Calmette-Guérin immunotherapy
por: Rezvani, Sean, et al.
Publicado: (2019) -
Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy
por: Klebanov, Nikolai, et al.
Publicado: (2018) -
Multiparametric ultrasound findings of tuberculous orchitis following bacillus Calmette-Guérin therapy
por: Ahmed, Rumman, et al.
Publicado: (2017) -
Tuberculosis Epididymo-Orchitis Mimicking Malignancy Resulting from Intravesical Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: A Case Report of a Rare Complication
por: Chiu, Liang-Wei, et al.
Publicado: (2022) -
Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)